Escherichia coli msbB gene as a virulence factor and a therapeutic target
about
Gram-positive and gram-negative bacterial toxins in sepsis: a brief reviewRetargeting R-type pyocins to generate novel bactericidal protein complexesFocus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic SystemsStructure-guided enzymology of the lipid A acyltransferase LpxM reveals a dual activity mechanismHigh yield production process for Shigella outer membrane particlesmsbB deletion confers acute sensitivity to CO2 in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwfVirulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutantsConstruction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice.Mouse paneth cell secretory responses to cell surface glycolipids of virulent and attenuated pathogenic bacteria.Involvement of the Escherichia coli O157:H7(pO157) ecf operon and lipid A myristoyl transferase activity in bacterial survival in the bovine gastrointestinal tract and bacterial persistence in farm water troughs.Use of preferentially replicating bacteria for the treatment of cancer.Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infectionThe structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.PCR for specific detection of H7 flagellar variant of fliC among extraintestinal pathogenic Escherichia coli.Extragenic suppressors of growth defects in msbB Salmonella.Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation.Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice.Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infectionsAn msbB homologue carried in plasmid pO157 encodes an acyltransferase involved in lipid A biosynthesis in Escherichia coli O157:H7.Construction of Escherichia coli Mutant with Decreased Endotoxic Activity by Modifying Lipid A Structure.Salmonella enterica serovar Typhimurium expressing mutant lipid A with decreased endotoxicity causes maturation of murine dendritic cellsSensing gram-negative bacterial lipopolysaccharides: a human disease determinant?Characterization of htrB and msbB mutants of the light organ symbiont Vibrio fischeri.Construction of monophosphoryl lipid A producing Escherichia coli mutants and comparison of immuno-stimulatory activities of their lipopolysaccharidesSpecies-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by Colistin In Vitro and In VivoSecondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptidesStructural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles.PagP activation in the outer membrane triggers R3 core oligosaccharide truncation in the cytoplasm of Escherichia coli O157:H7.Secondary acylation of Vibrio cholerae lipopolysaccharide requires phosphorylation of Kdo.The oral microbial consortium's interaction with the periodontal innate defense system.Differential regulation by magnesium of the two MsbB paralogs of Shigella flexneri.Progress in the synthesis and biological evaluation of lipid A and its derivatives.Characterization of a novel intracellularly activated gene from Salmonella enterica serovar typhiPolymyxin B resistance in El Tor Vibrio cholerae requires lipid acylation catalyzed by MsbB.Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.Role of lipid A acylation in Yersinia enterocolitica virulenceBacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response.Bacteria as tumor therapeutics?
P2860
Q22305427-24D0382B-389F-4C60-AB13-79A17F017D6DQ24647143-E49DB0F0-DE5D-4350-A7CB-0CEB3AC56149Q26767267-F6E48BF9-7FE2-409A-9CC8-07CAA5841522Q27728135-B7D8F838-C306-4DC3-80E8-F7CAF76EA327Q28728768-3F6678B0-952F-4F4E-93AC-EAD0DB3078D2Q33494726-9901931A-4113-4D65-B31A-9FDCBFAE9CA1Q33557800-3AB07EDF-3F73-4C73-B3A9-491D9CEE36FDQ33725162-7E42D73F-1C9D-4C37-84DD-F75198C5073BQ33769179-354406BD-0802-4F46-8902-1D59D97FF9D7Q33769305-110C2907-7DC1-44EB-BFAF-8F7E32EDD8EFQ33895307-B3C46347-6369-447D-A6B8-74BD9885CB50Q33938093-F6AA1A5E-984E-4776-B5DE-9F3425D9728BQ33963083-78A3DD28-1C15-47A9-8F9A-795A52170F2EQ33973725-758183CF-EB9D-4663-9312-AA37A9303A33Q33996895-E5346512-6E7A-4CDF-97C8-58F1EDC7EE50Q34353996-B32605CE-F7D6-43D4-847E-23FE78FE2153Q34394184-D77D305F-7526-4D14-8A74-C9A446E7D503Q34394744-E1D46F54-7F16-4E5C-97D7-A9C0321562A8Q34518568-1CAF58FC-141E-4C18-B184-55C2F0934AB7Q34953603-34CF8623-BCF4-43F9-9744-B588BD1123B7Q35548977-1DCA6C20-8B79-4124-AF13-8AB04A1E6F0BQ35790719-68EA98CC-7166-4FFA-ADC9-BB36B590F460Q36375529-CF3D58B3-3F7E-4E16-B457-3B28E8CBAA21Q36421502-F93B5B2D-4947-4A2E-BED8-3FF9982945DDQ36430606-E5EE0A99-1872-4EDD-95C7-62176264AB34Q36806692-1627CD7D-9B04-4124-8C6F-C615DCC3B06BQ37124122-9806B5C5-866D-4DB9-8943-1D80FB9EAAB7Q37222605-09AC343F-6EFA-485E-9BF0-50994FECAC0BQ37222609-9735CB3A-59D0-44F8-A515-89D691895BFEQ37222618-BFC33104-EAC3-4A7D-8D52-B99DB2B65269Q37377687-8991E232-D820-4114-840E-D9C94B6A36A3Q37478630-7AD4C187-6622-4C51-912B-7EA4CDBCC057Q38608685-C03CCFE4-164A-4F21-A292-FA94C509EF3DQ39378325-0ED7FAFA-6FA0-4320-B7AF-98C190047814Q39656605-5BC5F986-D8BC-418B-8CB4-12AC0D36D45BQ39739730-4B7800FE-F74B-4A52-966A-70BBBF6CEEEDQ40014914-F05868F9-C987-445A-A69F-F36905326057Q40755880-12664E9A-283D-4966-8873-DA06A4DA2D0FQ41701099-DF9C9302-2E11-4C0B-B6EC-E3F22D251F7DQ42579545-B6693B8B-5C5D-4605-80AA-3AF192455D4F
P2860
Escherichia coli msbB gene as a virulence factor and a therapeutic target
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Escherichia coli msbB gene as a virulence factor and a therapeutic target
@en
Escherichia coli msbB gene as a virulence factor and a therapeutic target.
@nl
type
label
Escherichia coli msbB gene as a virulence factor and a therapeutic target
@en
Escherichia coli msbB gene as a virulence factor and a therapeutic target.
@nl
prefLabel
Escherichia coli msbB gene as a virulence factor and a therapeutic target
@en
Escherichia coli msbB gene as a virulence factor and a therapeutic target.
@nl
P2093
P2860
P1476
Escherichia coli msbB gene as a virulence factor and a therapeutic target
@en
P2093
J E Somerville
L Cassiano
R P Darveau
P2860
P304
P407
P577
1999-12-01T00:00:00Z